ANIK icon

Anika Therapeutics
ANIK

Overview Fund Activity

160 hedge funds and large institutions have $617M invested in Anika Therapeutics in 2016 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 52 increasing their positions, 63 reducing their positions, and 17 closing their positions.

Holders
160
Holders Change
-2
Holders Change %
-1.23%
% of All Funds
4.28%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
16
Increased
52
Reduced
63
Closed
17
Calls
$2.01M
Puts
$2.76M
Net Calls
-$753K
Net Calls Change
-$1.62M

Top Buyers

1
EA
1
Emerald Acquisition
Washington
$6.54M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$43.8M
3
PCM
3
Piermont Capital Management
Missouri
$4.32M
4
AQR Capital Management
4
AQR Capital Management
Connecticut
$5.61M
5
TI
5
Turner Investments
Pennsylvania
$2.41M

Top Sellers

1
TSW
1
Thompson Siegel & Walmsley
Virginia
$32.2M
2
FAM
2
Fred Alger Management
New York
$0
3
NAP
3
New Amsterdam Partners
New York
$0
4
PCM
4
Portolan Capital Management
Massachusetts
$2.77M
5
HP
5
HealthInvest Partners
Sweden
$22.1M
Name Market Value Shares Shares
Change 		Shares
Change %
MFS
176
MSI Financial Services
Massachusetts
– – -1,373 Closed
Simplex Trading
177
Simplex Trading
Illinois
– – -211 Closed
4 5 6 7
8